Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

  • Technology appraisal guidance
  • TA121
  • Published: 

2007/034 NICE issues guidance on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

NICE has issued guidance today (27 June 2007) on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma, a type of cancerous brain tumour.

This page was last updated: 13 August 2007